FDA Approves IND Clearance for Innovative Immunoglobulin Eye Drops Targeting Dry Eye Disease Selagine, Inc. announces FDA's clearance for their immunoglobulin eye drops aimed at alleviating symptoms for dry eye disease patients, marking a significant advancement.

FDA Approves IND Clearance for Innovative Immunoglobulin Eye Drops Targeting Dry Eye Disease #USA #Chicago #Dry_Eye #Selagine #Immunoglobulin